VIRUSES AND HEMATOPOEIESIS
VIRUSES AND HEMATOPOEIESIS
批准号:
6162707
负责人:
N S YOUNG
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AIDS vaccines Parvoviridae adeno associated virus group capsid clinical research clinical trial phase I drug design /synthesis /production gene expression gene therapy genetic transduction hematopoiesis human immunodeficiency virus 1 human subject human therapy evaluation immunohematology receptor binding tissue /cell culture transfection /expression vector vaccine development vector vaccine viral vaccines virus genetics virus integration virus protein virus receptors
中文摘要
造血细胞与病毒相互作用的研究已经取得了进展
集中在细小病毒科和黄病毒科有趣的成员
家人。B19细小病毒感染红系祖细胞和
人类感染导致两种血液学综合征一过性
再生障碍性贫血危象和纯红细胞再生障碍性贫血
儿童期皮疹第五病。被B19的报道激怒了
细小病毒可能参与了急性暴发型肺炎的发病。
肝炎综合征,我们已经使用聚合酶链分析
反应了大量的肝脏样本:根据我们的经验,
大约30%的肝组织含有可检测到的B19细小病毒,
不管最初的诊断是什么。这些结果表明,
病毒在没有药物治疗的情况下可能会在内脏组织中持续少量存在
后果。我们还发现了另一个成员并对其进行了描述
属于感染猪尾猕猴的红血球病毒属。这
和其他红血球病毒有相同的基因同源性和功能
具有B19细小病毒的特征。猿猴属的一种成员,猿猴
细小病毒可能为人类疾病提供了一种动物模型,如积水
致命的是通过实验性的子宫接种在
怀孕的中期。在疫苗试验中,恒河猴有
用配制的空B19细小病毒衣壳免疫
使用几种实验性佐剂,以诱导高滴度的
中和抗体。一个这样的提法应该被证明是合适的
一种预防细小病毒病的人类疫苗。其他病毒研究
包括腺相关病毒成员的克隆和测序
AAV属,其组织向向性不同于传统的
AAV-2;进一步的实验以确定细胞表面的性质
AAV-2受体及非结构蛋白的功能分析
B19细小病毒的蛋白质,负责杀死病毒细胞。
在黄病毒科、庚型肝炎或GBV-C中,一个新的成员
黄疫病毒群,已通过基因扩增在一株
大量正常个体:约为正常个体的6%
越南人是病毒携带者,最近对越南儿童进行了研究
华盛顿地区显示,9%的血浆样本含有GBV-C序列。
到目前为止测序的所有分离株的遗传异质性都很高。
GBV-C是否代表了一种真正的肝炎病毒,它的组织嗜性,
在没有核心蛋白的情况下复制的性质,以及
病毒感染与疾病的关系仍然是当前的重要趋势
问题。
英文摘要
Studies of the interaction of hematopoietic cells and viruses have
concentrated on interesting members of the Parvoviridae and Flaviviridae
families. B19 parvovirus infects erythroid progenitor cells and
infection in humans causes both the hematologic syndromes transient
aplastic crisis and pure red cell aplasia as well as the common
childhood exanthem fifth disease. Provoked by reports that B19
parvovirus might be involved in the etiology of acute and fulminant
hepatitis syndromes, we have analyzed using the polymerase chain
reaction a large number of liver samples: in our experience,
approximately 30% of liver tissue contain detectable B19 parvovirus,
regardless of the primary diagnosis. These results suggest that the
virus may persist in small amounts in visceral tissue without medical
consequence. We have also discovered and characterized another member
of the Erythrovirus genus that infects pig-tailed macaque monkeys. This
and other Erythroviruses share genetic homology and functional
characteristics with B19 parvovirus. One member of the genus, simian
parvovirus, may offer an animal model for human disease, as hydrops
fatalis has been reproduced by experimental uterine inoculation during
the mid-trimester of pregnancy. In vaccine trials, rhesus monkeys have
been immunized with empty B19 parvovirus capsids that were formulated
with several experimental adjuvants in order to elicit high titers of
neutralizing antibodies. One such formulation should prove appropriate
for a human vaccine to prevent parvovirus disease. Other viral studies
include cloning and sequencing of a member of the adeno-associated virus
genus (AAV), the tissue tropism of which differs from the conventional
AAV-2; further experiments to determine the nature of the cell surface
receptor for AAV-2; and functional analysis of the non-structural
protein of B19 parvovirus, which is responsible for viral cell killing.
Of the Flaviviridae, hepatitis G or GBV-C, a novel member of the
flavi-pestivirus group, has been detected by gene amplification in a
large number of normal individuals: approximately 6% of normal
Vietnamese are viremic and more recent studies of children in the
Washington area show that 9% of plasma samples contain GBV-C sequences.
Genetic heterogeneity is high among all isolates sequenced to date.
Whether GBV-C represents a true hepatitis virus, its tissue tropism, the
nature of replication in the absence of a core protein, and the
relationship of viral infection to disease remain important current
questions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PATHOGENESIS AND TREATMENT OF APLASTIC ANEMIA
-
批准号:5203539
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
PATHOGENESIS AND TREATMENT OF APLASTIC ANEMIA
-
批准号:3779565
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
PATHOGENESIS AND TREATMENT OF APLASTIC ANEMIA
-
批准号:3843328
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
PAROVIRUS (HUMAN) B19
-
批准号:3858051
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
PAROVIRUS
-
批准号:3942851
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
PATHOGENESIS AND TREATMENT OF APLASTIC ANEMIA
-
批准号:3757655
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
LYMPHOCYTES AND LMYPHOKINES IN APLASTIC ANEMIA
-
批准号:3966619
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
LYMPHOCYTES AND LMYPHOKINES IN APLASTIC ANEMIA
-
批准号:3942850
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
PATHOGENESIS AND TREATMENT OF APLASTIC ANEMIA
-
批准号:2576795
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
B19 PARVOVIRUS AND ADENO-ASSOCIATED VIRUS
-
批准号:3757656
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
PAROVIRUS (HUMAN) B19
-
批准号:3779566
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
LYMPHOCYTES AND LMYPHOKINES IN APLASTIC ANEMIA
-
批准号:4694580
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
B19 PARVOVIRUS AND ADENO-ASSOCIATED VIRUS
-
批准号:5203540
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
PAROVIRUS (HUMAN) B19
-
批准号:3920069
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
PATHOGENESIS AND TREATMENT OF APLASTIC ANEMIA
-
批准号:3878966
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
PATHOGENESIS AND TREATMENT OF APLASTIC ANEMIA
-
批准号:3858050
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
VIRUSES AND BONE MARROW FAILURE
-
批准号:3966621
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
VIRUSES AND HEMATOPOEIESIS
-
批准号:2576796
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
PATHOGENESIS AND TREATMENT OF APLASTIC ANEMIA
-
批准号:6162706
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
LYMPHOCYTES AND LMYPHOKINES IN APLASTIC ANEMIA
-
批准号:3920068
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:N S YOUNG
-
依托单位:
海外基金